Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

August 21, 2008

Its all about the spin

This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Marc Hamet, MD, PresidentMarc Hamet, MD
President, Image Guided Therapeutics, LLC.
Implications: This article could easily be spun as a victory for stent efficacy.

Analysis:  In essence, this article is stating that at about 3 years, there is no significant outcome between patients that have traditional pharmacalogical intervention and those that recieve cardiac stents.  This sounds a lot like a great victory for stents!  Medication compliance is a chronic problem all clinicians encounter on a regular basis.  A prescription of lifestyle modification is often the hardest for the patient to follow.  Stents have never proported to be a panacea for cardiovascular disease, but I think that this study could easily be spun to show that patients can avoid medications and their side effects for 3 years.  Of course, in practice, any patient that receives a stent will also be treated with an appropriate medical regimen.  A study of stent plus medication versus medication alone would be more meaningful.

Other Analyses of the Same Source Article:
COURAGE - flawed trial as it compares optimum medical therapy with sub-optimum PCI
September 11, 2008, Author: GLG Expert Contributor
The trial that is all about hype
August 28, 2008, Author: GLG Expert Contributor
Minimal Impact on Stent Market
August 21, 2008, Author: GLG Expert Contributor
PCI numbers will not drop after Courage
August 19, 2008, Author: GLG Expert Contributor
Bad News (but not new news) for stents.
August 19, 2008, Author: GLG Expert Contributor
Courage trial should redefine care in America
August 18, 2008, Author: GLG Expert Contributor
Stents vs Coronary Surgery
August 18, 2008, Author: GLG Expert Contributor
Not too surprising a result
August 18, 2008, Author: GLG Expert Contributor
Stents vs. Drugs: Same for Patients, Very Different for Providers
August 18, 2008, Author: GLG Expert Contributor
Less and less evidence to favor coronary stenting
August 15, 2008, Author: GLG Expert Contributor

Report a Concern

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-11-20T09:45:18.440